An evaluation of the sensitivity of the Ames assay to discern low-level mutagenic impurities.
暂无分享,去创建一个
Warren W Ku | Krista L Dobo | M. Kenyon | W. Ku | Michelle O Kenyon | Jennifer R Cheung | J. Cheung | K. Dobo
[1] Lutz Müller,et al. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. , 2006, Regulatory toxicology and pharmacology : RTP.
[2] M. Eichelbaum,et al. Identification of P450 enzymes involved in metabolism of verapamil in humans , 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.
[3] J E Ridings,et al. Computer prediction of possible toxic action from chemical structure: an update on the DEREK system. , 1996, Toxicology.
[4] T Satoh,et al. Advantage of the use of human liver S9 in the Ames test. , 1999, Mutation research.
[5] E. Zeiger,et al. Salmonella mutagenicity test results for 250 chemicals. , 1983, Environmental mutagenesis.
[6] C. Bonfils,et al. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. , 1990, Drug metabolism and disposition: the biological fate of chemicals.
[7] T. Satoh,et al. Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors. , 2003, Regulatory toxicology and pharmacology : RTP.
[8] R. Riley,et al. Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[9] R. Riggin,et al. Characterization of impurities in commercial lots of sodium saccharin produced by the Sherwin-Williams process. II. Mutagenicity. , 1983, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[10] G. Kondos,et al. Near-total reduction in verapamil bioavailability by rifampin. Electrocardiographic correlates. , 1988, Chest.
[11] E. G. Lovering,et al. Determination of hydrazine in pharmaceuticals III: hydralazine and isoniazid using GLC. , 1983, Journal of pharmaceutical sciences.
[12] B. Ames,et al. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Wold,et al. Chemical purity and mutagenicity: case study of a drug in development. , 1992, Mutation research.
[14] N Flamand,et al. Mini mutagenicity test: a miniaturized version of the Ames test used in a prescreening assay for point mutagenesis assessment. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.
[15] J. Topinka,et al. Bioassay-directed chemical analysis and detection of mutagenicity in ambient air of the coke oven. , 1999, Mutation research.
[16] Detection of oxidative mutagens in an urban air-particulate extract: a preliminary study. , 1992, Mutation research.
[17] P N Judson,et al. Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. , 1999, SAR and QSAR in environmental research.
[18] B. Ames,et al. Revised methods for the Salmonella mutagenicity test. , 1983, Mutation research.
[19] D J Judah,et al. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[20] H. Utsumi,et al. Mutagenicity Characteristics of 255 Environmental Chemicals , 2002 .
[21] J. Epler,et al. Short-Term Bioassay of Complex Organic Mixtures: Part I, Chemistry , 1978 .
[22] Andreas Hartmann,et al. Towards the creation of an international toxicology information centre. , 2005, Toxicology.
[23] M. Murray,et al. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites. , 1997, The Journal of pharmacology and experimental therapeutics.
[24] E. Zeiger,et al. Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals , 1992, Environmental and molecular mutagenesis.
[25] E. Zeiger,et al. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. , 1987, Environmental mutagenesis.
[26] D. Brusick,et al. The Salmonella typhimurium/mammalian microsomal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program. , 1986, Mutation research.
[27] D. Sanderson,et al. Computer Prediction of Possible Toxic Action from Chemical Structure; The DEREK System , 1991, Human & experimental toxicology.
[28] B. Burlinson,et al. Use of the Miniscreen assay to screen novel compounds for bacterial mutagenicity in the pharmaceutical industry. , 1996, Mutagenesis.
[29] E. Zeiger,et al. Handbook of Carcinogenic Potency and Genotoxicity Databases , 1996 .
[30] J. K. Clark,et al. Is Mannitol Metabolized?∗ , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[31] D J Brusick,et al. International Commission for Protection Against Environmental Mutagens and Carcinogens. A method for comparing and combining short-term genotoxicity test data: the basic system. , 1992, Mutation research.
[32] S. De Flora,et al. Modulation of the potency of promutagens and direct acting mutagens in bacteria by inhibitors of the multidrug resistance mechanism. , 1997, Mutagenesis.
[33] O. Pelkonen,et al. Inhibition of hepatic microsomal drug metabolism in rats by five calcium antagonists. , 1989, Pharmacology & toxicology.
[34] T. Shimada,et al. Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes. , 1987, Toxicology and applied pharmacology.
[35] Evaluation of the genotoxicity of process stream extracts from a coal gasification system. , 1984, Environmental mutagenesis.
[36] E. Zeiger,et al. Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals , 1988, Environmental and molecular mutagenesis.
[37] M D Waters,et al. The Genetic Activity Profile database. , 1991, Environmental health perspectives.
[38] R. Snyder,et al. Comparison of the results of a modified miniscreen and the standard bacterial reverse mutation assays , 2000, Environmental and molecular mutagenesis.
[39] E. Gocke,et al. Mutagenicity study of Remsen-Fahlberg saccharin and contaminants. , 1980, Toxicology letters.
[40] Mutagenicity and toxicity of aflatoxin precursors. , 1982, Environmental mutagenesis.
[41] E. S. West,et al. On the metabolism of scrbitol and mannitol. , 1939 .
[42] W. Seinen,et al. BACTERIAL MUTAGENICITY OF DICYCLOPENTA-FUSED PYRENE CONGENERS IN FVT-PYROLYSATES: PARTIAL COMBUSTION EXHAUST MIMICS , 2004 .
[43] K. Hamada,et al. The Effect of Diltiazem and Verapamil on Hepatic Microsomal Drug Metabolizing Enzymes in Rat , 1991 .
[44] E. Zeiger,et al. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. , 1986, Environmental mutagenesis.
[45] Hannu Komulainen,et al. Bacterial and mammalian‐cell genotoxicity of mixtures of chlorohydroxyfuranones, by‐products of water chlorination , 2004, Environmental and molecular mutagenesis.
[46] J. Berridge. Impurities in drug substances and drug products: new approaches to quantification and qualification. , 1995, Journal of pharmaceutical and biomedical analysis.
[47] Nigel Greene,et al. The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development. , 2006, Regulatory toxicology and pharmacology : RTP.
[48] Spiral Salmonella assay: Validation against the standard pour‐plate assay , 1996, Environmental and molecular mutagenesis.
[49] P. Lohman. Qualitative and quantitative procedures for health risk assessment. , 1999, Mutation research.
[50] D. Jones,et al. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation. , 1999, The Journal of pharmacology and experimental therapeutics.
[51] Sac-fry Stages,et al. OECD GUIDELINE FOR TESTING OF CHEMICALS , 2002 .
[52] L. Wheeler,et al. A comparison of aflatoxin B1-induced cytotoxicity, mutagenicity and prophage induction in Salmonella typhimurium mutagen tester strains TA1535, TA1538, TA98 and TA100. , 1981, Mutation research.